Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

251 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.
Knutson KL, Disis ML. Knutson KL, et al. Among authors: disis ml. Cancer Immunol Immunother. 2005 Aug;54(8):721-8. doi: 10.1007/s00262-004-0653-2. Epub 2005 Jan 27. Cancer Immunol Immunother. 2005. PMID: 16010587 Review.
Laboratory analysis of T-cell immunity.
Knutson KL, dela Rosa C, Disis ML. Knutson KL, et al. Among authors: disis ml. Front Biosci. 2006 May 1;11:1932-44. doi: 10.2741/1936. Front Biosci. 2006. PMID: 16368569
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.
Karyampudi L, Krco CJ, Kalli KR, Erskine CL, Hartmann LC, Goodman K, Ingle JN, Maurer MJ, Nassar A, Yu C, Disis ML, Wettstein PJ, Fikes JD, Beebe M, Ishioka G, Knutson KL. Karyampudi L, et al. Among authors: disis ml. Cancer Immunol Immunother. 2010 Jan;59(1):161-71. doi: 10.1007/s00262-009-0738-z. Epub 2009 Jul 21. Cancer Immunol Immunother. 2010. PMID: 19621224 Free PMC article.
Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response.
Wang LX, Shu S, Disis ML, Plautz GE. Wang LX, et al. Among authors: disis ml. Blood. 2007 Jun 1;109(11):4865-76. doi: 10.1182/blood-2006-09-045245. Epub 2007 Feb 6. Blood. 2007. PMID: 17284532 Free PMC article.
The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity.
Behrens MD, Wagner WM, Krco CJ, Erskine CL, Kalli KR, Krempski J, Gad EA, Disis ML, Knutson KL. Behrens MD, et al. Among authors: disis ml. Blood. 2008 Feb 1;111(3):1472-9. doi: 10.1182/blood-2007-10-117184. Epub 2007 Nov 20. Blood. 2008. PMID: 18029553 Free PMC article.
CD4 regulatory T cells in human cancer pathogenesis.
Knutson KL, Disis ML, Salazar LG. Knutson KL, et al. Among authors: disis ml. Cancer Immunol Immunother. 2007 Mar;56(3):271-85. doi: 10.1007/s00262-006-0194-y. Epub 2006 Jul 4. Cancer Immunol Immunother. 2007. PMID: 16819631 Review.
A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102.
Karyampudi L, Formicola C, Erskine CL, Maurer MJ, Ingle JN, Krco CJ, Wettstein PJ, Kalli KR, Fikes JD, Beebe M, Hartmann LC, Disis ML, Ferrone S, Ishioka G, Knutson KL. Karyampudi L, et al. Among authors: disis ml. Clin Cancer Res. 2010 Feb 1;16(3):825-34. doi: 10.1158/1078-0432.CCR-09-2781. Epub 2010 Jan 26. Clin Cancer Res. 2010. PMID: 20103660 Free PMC article.
Immunoediting of cancers may lead to epithelial to mesenchymal transition.
Knutson KL, Lu H, Stone B, Reiman JM, Behrens MD, Prosperi CM, Gad EA, Smorlesi A, Disis ML. Knutson KL, et al. Among authors: disis ml. J Immunol. 2006 Aug 1;177(3):1526-33. doi: 10.4049/jimmunol.177.3.1526. J Immunol. 2006. PMID: 16849459
IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice.
Knutson KL, Dang Y, Lu H, Lukas J, Almand B, Gad E, Azeke E, Disis ML. Knutson KL, et al. Among authors: disis ml. J Immunol. 2006 Jul 1;177(1):84-91. doi: 10.4049/jimmunol.177.1.84. J Immunol. 2006. PMID: 16785502
The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens.
Lu H, Knutson KL, Gad E, Disis ML. Lu H, et al. Among authors: disis ml. Cancer Res. 2006 Oct 1;66(19):9754-61. doi: 10.1158/0008-5472.CAN-06-1083. Cancer Res. 2006. PMID: 17018635
251 results
Jump to page
Feedback